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Abstract 
Skin picking disorder (SPD) and trichotillomania (TTM) are common and oftentimes disabling 
disorders. 125 participants with SPD and 152 with TTM undertook clinical and neurocognitive 
evaluation, and were grouped according to mild, moderate, or severe levels of psychosocial 
dysfunction. Relationships between functional impairment and other variables were explored 
using linear regression and categorical analyses. Greater functional impairment was associated 
with worse disease severity in both groups, and by later symptom onset and lower quality of life 
in TTM subjects. These results indicate that levels of self-reported psychosocial dysfunction 
have a strong association with specific clinical aspects of SPD and TTM.  
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1. Introduction 
 Skin picking disorder (SPD) and trichotillomania (TTM) and are often debilitating 
conditions (Christenson et al., 1991; Woods et al., 2006; Grant et al., 2012). Not everyone with 
SPD or TTM, however, reports significant psychosocial impairment, and variables associated 
with impairment have yet to be clearly delineated. Understanding why certain individuals with 
SPD and TTM are more psychosocially impaired than others may be important in order to 
identify potentially clinically useful subtypes and optimize treatment.  
Our hypothesis is that SPD and TTM reflect a complex clinical and cognitive interaction 
which exhibits itself in various levels of psychosocial dysfunction, and that the level of 
dysfunction may inform us about the heterogeneity within these disorders.  We sought to 
investigate the clinical and cognitive profiles of adults with various levels of dysfunction. Based 
on the extant literature (Tung et al., 2015; Chamberlain et al., 2006; Odlaug et al., 2010), we 
hypothesized that individuals with greater psychosocial dysfunction would exhibit more severe 
SPD and TTM and, on a cognitive level, would display greater impairment of response 
inhibition.  
 
2. Methods 
2.1 Subjects 
 Data from 125 adults with SPD and 152 with TTM taking part in various research studies 
at two university centers were included in this study. Inclusion criteria included males and 
females aged 18 to 65 years with a primary diagnosis of either SPD or TTM. Exclusion criteria 
included current psychotic disorders, bipolar disorder, or past six-month history of substance use 
disorders, and an inability to understand study procedures and provide written informed consent.  
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2.2 Assessments 
Current and lifetime psychiatric comorbidity was assessed using the Structured Clinical 
Interview for DSM-IV (SCID) disorders (First et al., 1995) and SCID-compatible modules for 
impulse control disorders (Grant et al., 2008). Adults with SPD completed the Yale–Brown 
Obsessive–Compulsive Scale Modified for Neurotic Excoriation (NE-YBOCS), a clinician-
administered scale examining urges to pick and picking behavior for the past week (Arnold et al., 
1999). Participants with TTM completed the Massachusetts General Hospital Hairpulling Scale 
(MGH-HPS) (Keuthen et al., 1995), a self-report assessment of TTM severity for the past week.  
In addition, all subjects completed the following: Sheehan Disability Scale (SDS) 
(Sheehan, 1983), Clinical Global Impression - Severity of Illness (CGI-S) (Guy, 1976), Quality 
of Life Inventory (QoLI) (Frisch et al., 1993), 17-item Hamilton Depression Rating Scale 
(Hamilton, 1960), and the Hamilton Anxiety Rating Scale (Hamilton, 1959).  
 
2.3 Cognitive Testing 
Cognitive assessments consisted of two previously validated tests taken from 
CANTABeclipse software. Previous research has found that individuals with SPD and TTM 
often exhibit significant deficits of motor inhibition and cognitive flexibility compared to healthy 
controls (Chamberlain et al., 2006; Odlaug et al., 2010). All testing was conducted in the same 
controlled environment, and the order of the tasks was fixed. 
Stop-signal task (SST). The Stop-signal task is a well-validated task quantifying the 
ability to suppress impulsive responses (Logan et al., 1984).   
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  Intra-dimensional/Extra-dimensional Set Shift task (IDED) (Owen et al., 1991). The 
IDED task includes aspects of rule learning and behavioral flexibility (Lezak, 2004).  
 
2.4 Data Analysis 
We used both a dimensional as well as a categorical approach and examined TTM and 
SPD groups separately. We used linear regression to examine the clinical and cognitive 
correlations with the SDS total score (all variables listed in Table 1, except duration of illness, 
were included in the regression analyses). Because linear regression is unfamiliar and arguably 
less useful to clinicians, we also examined the SDS total score in a categorical analysis. Based on 
the total SDS score, subjects were categorized as mild or no impairment (score 0 – 10), moderate 
psychosocial impairment (score of 11 – 20), or severe impairment (score of 21 – 30) based on the 
anchors provided by the scale (Sheehan et al., 1996).   
Potential differences between groups were explored using analysis of variance (ANOVA) 
(or chi-square for non-parametric tests as appropriate). This being an exploratory study, 
statistical significance was defined as p<0.05 uncorrected. SPSS Statistics version 18 (SPSS Inc., 
2009) was used for all analyses.  
 
3. Results 
125 adults with primary SPD and 152 participants with primary TTM took part in the 
study. Demographic characteristics in either group did not differ as a function of impairment 
(Table 1). 21 of 125 participants with primary SPD (16.8%) also had secondary TTM, and 40 
(26.3%) of those with primary TTM also had secondary SPD.  There was no overlap in the two 
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samples. Additionally, 64 (51.2%) of SPD participants had a current psychiatric disorder that 
was not TTM, and 67 (44.1%) of TTM subjects had a psychiatric disorder other than SPD. 
In the case of TTM, using linear regression with SDS total score as the dependent 
variable, there was a significant model identified (F=25.236, p<0.001) with MGH-HPS total 
score (i.e. worse disease severity) (t=7.021, p<0.001), the QoLI t-score (lower quality of life) 
(t=-2.515, p=0.013), and older age at onset (t=2.435, p=0.016) all being significant associated 
variables. In the categorical analysis for TTM participants (Table 1), there was a main effect of 
functional impairment level on age of onset (p=0.001), MGH-HPS total score (p<0.001), CGI-S 
(p<0.001), HAM-D (p=0.004), and HAM-A scores (0.012). Cognitive performance did not differ 
significantly contingent on functional impairment category (all p>0.10).  
In the case SPD, the linear regression analysis with SDS total score as the dependent 
variable identified a significant model (F=40.269, p<0.001) with NE-YBOCS total score being 
the only significantly associated variable (t=6.346, p<0.001). Thus, higher psychosocial 
dysfunction was significantly associated with worse disease severity. In the categorical analysis 
for SPD (Table 1), there was a significant effect of psychosocial function on NE-YBOCS total 
score (p<0.001), CGI-S (p<0.001), and QoLI t-score (p=0.025). Cognitive performance did not 
differ significantly as a function of psychosocial impairment (all p>0.10).  
 
4. Discussion 
In this study, we determined the clinical and cognitive correlates of psychosocial 
dysfunction in 152 individuals with TTM and 125 with SPD.  Both disorders demonstrated high 
rates of psychosocial dysfunction, with 56% of the adults with SPD and 44% of the TTM adults 
reporting moderate or severe impairment due to these behaviors. Not surprisingly, greater 
 7 
 
 
dysfunction in both disorders was associated with worse symptom severity, in the absence of 
potential confounding differences such as age, gender, and education levels. This is in keeping 
with previous research (Tucker et al., 2011; Woods et al., 2006). Because of the frequent 
noticeable scarring from picking and hair loss from pulling, it is not surprising that individuals 
would report problems in social and work environments.  
There were, however, some important clinical differences between TTM and SPD. 
Depression and anxiety were significant aspects of dysfunction in TTM using the categorical 
approach, whereas these were not significant for SPD. Our findings in TTM are consistent with a 
recent study which found that depressive and anxiety symptom severity impacted psychosocial 
functioning even in the absence of formal depression and anxiety diagnoses (Tung et al., 2015). 
One possible reason for the difference in our results between TTM and SPD could be the overall 
low depressive and anxiety symptoms reported by SPD participants in this study. With low 
levels of symptoms, significant differences would be more difficult to detect. Many people with 
SPD who also have severe depression and anxiety may choose not to participate in research 
protocols and instead seek treatment directly.  
Another important difference between TTM and SPD was the fact that older age at TTM 
onset was associated with greater impairment using both statistical approaches, and this was not 
the case in SPD. Because previous research has found that older age at TTM onset is associated 
with more severe hair pulling symptoms (Odlaug et al., 2012), this finding may reflect the notion 
that age at onset is associated with severity which, in turn, is associated with impairment.  
 There are several possible explanations for the associations between elevated dysfunction 
and more severe disorder-specific symptoms and, in the case of TTM, general psychosocial 
variables. One explanation might be that worse picking and pulling leads to greater psychosocial 
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dysfunction which, in the case of TTM, then leads to greater depression and anxiety. This 
explanation would prioritize the pulling as the nidus for the chain reaction of events. 
Alternatively, if the psychosocial dysfunction is fairly chronic then this could lead to worse 
symptom severity as the person is isolated, not getting out of the home and therefore pulls more 
or has less motivation to control the behavior. Finally, another explanation could be that certain 
variables such as anxiety and depression lead to worse pulling and in turn both create more 
psychosocial dysfunction. Given that this study did not examine causality, these explanations 
remain speculative.  
   
4.1 Limitations 
This study has several positive features, but some limitations should be considered.  First, 
impairment was examined with a self-report measure assessing only the past week. Second, the 
correlated variables all came from participants rather than collecting corroborative information 
from loved ones. Third, the majority of participants was female and so these findings may not 
apply to males. Fourth, the NE-YBOCS has questions regarding interference of symptoms on a 
person’s life and so may share some overlap with the SDS. Finally, the study is cross-sectional in 
nature and a prospective study may provide greater insight regarding the temporal relationship of 
TTM and SPD symptoms to psychosocial dysfunction.  
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Table 1. Characteristics of Individuals with Trichotillomania (n=152) or Skin Picking (n=125) Grouped by Level of Psychosocial Dysfunction 
Trichotillomania Participants Mild or No Dysfunction 
N=85
Moderate Dysfunction 
N=55 
Severe Dysfunction 
N=12 Test statistic p 
Degrees of 
freedom 
DEMOGRAPHICS  
Age 33.3 (11.1) 30.6 (10.4) 34.0 (12.3) 1.143 0.321 151 
Female, n (%) 75 (88.2) 50 (90.9) 11 (91.7) 0.519# 0.972 4 
Relationship Status, n (%) Married 34 (40.0) 14 (25.5) 6 (50.0) 6.580# 0.583 8 
Education, n (%) High school or less 
                              At least some college 
17 (20.0) 
68 (80.0) 
13 (23.6) 
42 (76.4) 
5 (41.7) 
7 (58.3) 
 
10.727# 
 
0.218 
 
8 
Unemployed, n (%) 2 (2.4) 1 (1.8) 0 (0) 15.068# 0.238 12 
CLINICAL AND COGNITIVE ASSOCIATIONS  
Age of Trichotillomania onset 11.5  (3.9) 14.0 (7.5) 17.8 (10.8) 6.993 0.001 151 
Duration of Illness (Trichotillomania) 21.8 (11.4) 16.6 (9.8) 16.2 (13.1) 4.343 0.015 151 
MGH-HPS total score 15.7 (4.5) 19.3 (3.1) 21.9 (2.4) 21.906 <0.001 151 
CGI-S 4.3 (0.7) 4.7 (0.8) 5.1 (0.8) 10.109 <0.001 151 
HAM-D 3.9 (3.1) 4.3 (3.6) 7.8 (6.5) 5.782 0.004 151 
HAM-A 3.9 (3.1) 4.3 (3.4) 7.0 (4.7) 4.585 0.012 151 
QOLI t-score 29.0 (23.7) 25.9 (22.7) 17.8 (38.5) 1.132 0.334 149 
Any current comorbid psychiatric disorder, n (%) 34 (40.0) 28 (50.9) 5 (41.7) 1.643# 0.440 2 
IDED: Total errors, adjusted 21.7 (26.6) 24.3 (20.2) 31.3 (23.8) 0.466 0.629 87 
SST: SSRT 178.8 (52.8) 188.9 (62.5) 177.1 (42.2) 0.348 0.702 85 
Skin Picking Participants Mild or No Dysfunction 
N=55
Moderate Dysfunction 
N=59 
Severe Dysfunction 
N=11 Test statistic p 
Degrees of 
freedom 
DEMOGRAPHICS  
Age 35.9 (13.1) 33.0 (11.2) 31.3 (7.4) 1.254 0.289 124 
Female, n (%) 49 (89.1) 50 (90.1) 10 (90.1) 1.451# 0.835 2 
Relationship Status, n (%)  Married 21 (38.2) 27 (45.8) 2 (18.2) 8.449# 0.207 6 
Education, n (%) High school or less 
                              At least some college 
3 (5.5) 
52 (94.5) 
2 (3.4) 
57 (96.6) 
1 (9.1) 
10 (90.9) 
 
5.795# 
 
0.832 
 
10 
Unemployed, n (%) 6 (10.9) 1 (1.7) 0 (0) 15.366# 0.222 12 
CLINICAL AND COGNITIVE ASSOCIATIONS  
Age of skin picking onset 13.4 (11.1) 13.2 (7.4) 9.5 (4.3) 0.907 0.407 124 
Duration of Illness (Skin Picking Disorder) 22.5 (12.9) 19.8 (12.6) 21.8 (10.1) 0.683 0.507 124 
NE-YBOCS total score 16.6 (4.4) 19.4 (4.6) 24.9 (4.7) 17.225 <0.001 124 
CGI-S 4.0 (0.6) 4.4 (0.7) 5.0 (0.9) 13.302 <0.001 124 
HAM-D 4.7 (3.9) 4.3 (4.0) 5.1 (3.4) 0.230 0.795 124 
HAM-A 4.8 (4.1) 4.0 (3.3) 4.9 (3.1) 0.845 0.432 124 
QOLI t-score 42.8 (10.9) 44.9 (10.6) 34.5 (18.1) 3.820 0.025 123 
Any current comorbid psychiatric disorder, n (%) 26 (47.3) 30 (50.8) 9 (81.8) 4.442# 0.108 2 
IDED: Total errors, adjusted 21.7 (17.4) 20.7 (19.4) 18.8 (16.9) 0.099 .906 89 
SST: SSRT 196.6 (66.3) 207.6 (105.4) 184.2 (53.8) 0.327 .722 89 
All values are mean (SD) unless otherwise indicated. Test statistic is ANOVA unless indicated # (chi-square). 
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CGI-S=Clinical Global Impression – Severity of Illness; HAM-A=Hamilton Anxiety Rating Scale; HAM-D=Hamilton Depression Rating Scale; QOLI=Quality of Life Inventory; 
IDED= Intra-dimensional/Extra-dimensional Set Shift task; SST=Stop Signal Task; SSRT=Stop Signal Reaction Time 
